Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers

NCT02590640 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02590640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02590640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers
Lead sponsor
University of Colorado, Denver
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2015
Completion date
September 6, 2019
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking